Lead Product(s) : Entrectinib
Therapeutic Area : Oncology
Study Phase : Approved FDF
Sponsor : Chugai Pharmaceutical
Deal Size : Undisclosed
Deal Type : Agreement
Thermo Fisher Signs CDx Agreement with Chugai Pharma
Details : Approval by the MHLW would accelerate access to Chugai's targeted therapy via a locally administered, next-generation sequencing (NGS) biomarker test.
Product Name : Rozlytrek
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
August 07, 2020
Lead Product(s) : Entrectinib
Therapeutic Area : Oncology
Highest Development Status : Approved FDF
Sponsor : Chugai Pharmaceutical
Deal Size : Undisclosed
Deal Type : Agreement
Reset All
